Cargando…

Lung transplantation for bronchiolitis obliterans after hematopoietic stem cell transplantation: a retrospective single-center study

BACKGROUND: Bronchiolitis obliterans (BO) is one of the most common late non-infectious pulmonary complications after hematopoietic stem cell transplantation (HSCT). Lung transplantation (LT) is the only cure for patients with end-stage BO, but the overall efficacy is rarely reported. Our study aims...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Jialong, Chen, Yuan, Zhou, Jintao, Li, Huixing, Zheng, Mingfeng, Liu, Feng, Ye, Shugao, Chen, Jingyu, Ji, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279806/ https://www.ncbi.nlm.nih.gov/pubmed/35845538 http://dx.doi.org/10.21037/atm-22-2517

Ejemplares similares

Postinfectious bronchiolitis obliterans in children: lessons from bronchiolitis obliterans after lung transplantation and hematopoietic stem cell transplantation
por: Yu, Jinho
Publicado: (2015)

Lung Transplantation for Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation
por: Kim, Yu Ri, et al.
Publicado: (2012)

Lung Histology Predicts Outcome of Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation
por: Holbro, Andreas, et al.
Publicado: (2013)

Inhaled Bronchodilators and Corticosteroids in the Management of Bronchiolitis Obliterans due to Allogenic Hematopoietic Stem Cell Transplantation
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2022)

Beyond Bronchiolitis Obliterans: In-Depth Histopathologic Characterization of Bronchiolitis Obliterans Syndrome after Lung Transplantation
por: Vanstapel, Arno, et al.
Publicado: (2021)

Update on Bronchiolitis Obliterans Syndrome in Lung Transplantation
por: Lin, Christine M., et al.
Publicado: (2014)

Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation
por: Rhee, Chin Kook, et al.
Publicado: (2016)

Bilateral Lung Transplantation for Congenital Pulmonary Arteriovenous Fistula with Intraoperative Venovenous ECMO Support: The First Case Report in China
por: Liang, Jialong, et al.
Publicado: (2022)

LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats
por: Tu, Zheng-Liang, et al.
Publicado: (2017)

Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
por: Kim, Sei Won, et al.
Publicado: (2016)

Ruxolitinib treatment for bronchiolitis obliterans syndrome following hematopoietic stem cell transplant in a patient with primary hemophagocytic lymphohistiocytosis
por: Meng, Guang-Qiang, et al.
Publicado: (2021)

High-Expressed Macrophage Scavenger Receptor 1 Predicts Severity Clinical Outcome in Transplant Patient in Idiopathic Pulmonary Fibrosis Disease
por: Zheng, Mingfeng, et al.
Publicado: (2021)

Bronchiolitis obliterans
por: King, Talmadge E.
Publicado: (1989)

S290: DEVELOPMENT AND VALIDATION OF A PROGNOSTIC MODEL OF BRONCHIOLITIS OBLITERANS SYNDROME IN ADULT PATIENTS FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Huang, Qiu-Sha, et al.
Publicado: (2023)

Early Pathologic Findings of Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation: A Proposal from a Case
por: Nakamoto-Matsubara, Rie, et al.
Publicado: (2012)

Efficacy and safety of high-dose budesonide/formoterol in patients with bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplant
por: Kim, Kyung Hoon, et al.
Publicado: (2020)

Clinical and pathological features of bronchiolitis obliterans requiring lung transplantation in paraneoplastic pemphigus associated with Castleman disease
por: Chen, Wenhui, et al.
Publicado: (2022)

Association between chronic bacterial airway infection and prognosis of bronchiolitis obliterans syndrome after hematopoietic cell transplantation
por: Yomota, Makiko, et al.
Publicado: (2019)

Bronchiolitis Obliterans after Allogenic Bone Marrow Transplantation: HRCT Findings
por: Jung, Jung Im, et al.
Publicado: (2004)

The role of epithelial-mesenchymal transition in the post-lung transplantation bronchiolitis obliterans
por: Zhang, Chong, et al.
Publicado: (2017)

Chest computed tomography in bronchiolitis obliterans after bone marrow transplantation
por: Hochhegger, Bruno, et al.
Publicado: (2017)

Lung clearance index in detection of post-transplant bronchiolitis obliterans syndrome
por: Driskel, Madeleine, et al.
Publicado: (2019)

Bronchiolitis Obliterans With Recurrent Pneumothorax After Allogeneic Bone Marrow Transplantation
por: Akatsuka, Masayuki, et al.
Publicado: (2023)

Oxygen-sensitive (3)He-MRI in bronchiolitis obliterans after lung transplantation
por: Gast, Klaus Kurt, et al.
Publicado: (2007)

Clinical analysis of adenovirus postinfectious bronchiolitis obliterans and nonadenovirus postinfectious bronchiolitis obliterans in children
por: Huang, Fei, et al.
Publicado: (2021)

Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions
por: Glanville, Allan R., et al.
Publicado: (2022)

Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis
por: Bergeron, A, et al.
Publicado: (2012)

Combination of pleuroparenchymal fibroelastosis with non-specific interstitial pneumonia and bronchiolitis obliterans as a complication of hematopoietic stem cell transplantation — Clues to a potential mechanism
por: Oo, Zun Pwint, et al.
Publicado: (2019)

Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial
por: Ruttens, David, et al.
Publicado: (2018)

The role of HIF-1α-VEGF pathway in bronchiolitis obliterans after lung transplantation
por: Xu, Haichao, et al.
Publicado: (2019)

Involvement of IL-26 in bronchiolitis obliterans syndrome but not in acute rejection after lung transplantation
por: Magnusson, Jesper M., et al.
Publicado: (2022)

Comparative analysis of morphological and molecular motifs in bronchiolitis obliterans and alveolar fibroelastosis after lung and stem cell transplantation
por: Jonigk, Danny, et al.
Publicado: (2016)

A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation
por: Iacono, Aldo, et al.
Publicado: (2019)

Mycoplasma pneumoniae–Associated Bronchiolitis Obliterans Following Acute Bronchiolitis
por: Zhao, Chengsong, et al.
Publicado: (2017)

Increased plasma mannose binding lectin levels are associated with bronchiolitis obliterans after lung transplantation
por: Budd, Steven J, et al.
Publicado: (2012)

Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective
por: Cavallaro, Dalila, et al.
Publicado: (2022)

Double lung, unlike single lung transplantation might provide a protective effect on mortality and bronchiolitis obliterans syndrome
por: Fakhro, Mohammed, et al.
Publicado: (2017)

Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation
por: Zhao, Yanmin, et al.
Publicado: (2021)

Bronchiolitis obliterans syndrome following SARS-CoV-2 infection in an allogeneic hematopoietic stem cell recipient
por: Bondeelle, Louise, et al.
Publicado: (2023)

Evaluation of safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells in pediatric bronchiolitis obliterans syndrome (BoS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT)
por: Mohseni, Rashin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0rv6lufo7sd6jp04sk2dsrqp0l